The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical characteristics and outcome of a large cohort of patients with primary central nervous system (CNS) tumors and tropomyosin receptor kinase (TRK) fusion.
 
Audrey-Anne Lamoureux
No Relationships to Disclose
 
Michael J. Fisher
Research Funding - Array BioPharma; AstraZeneca; Exelixis
(OPTIONAL) Uncompensated Relationships - AstraZeneca; SpringWorks Therapeutics
 
Lauriane Lemelle
No Relationships to Disclose
 
Elke Pfaff
No Relationships to Disclose
 
Stefan M. Pfister
Research Funding - Bayer (Inst); Lilly (Inst); Pfizer (Inst); PharmaMar (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - patent on utilizing DNA methylation profiling for tumor classification
 
Dominik Sturm
No Relationships to Disclose
 
David T.W. Jones
No Relationships to Disclose
 
Daniel Orbach
Honoraria - Bayer Health (Inst); Bayer Health (Inst); EUSA Pharma (Inst); Novartis (Inst); Roche (Inst)
Consulting or Advisory Role - Bayer
Research Funding - Bayer (Inst)
 
Scott Raskin
No Relationships to Disclose
 
Alexander E. Drilon
Stock and Other Ownership Interests - Treeline Biosciences
Honoraria - Answers in CME; Associazione Italiana Oncologia Toracica (AIOT); AstraZeneca; BeiGene; Chugai Pharma; Clinical Care Options/NCCN; Helsinn Therapeutics; IASLC; Ignyta/Genentech/Roche; Liberum; Loxo/Bayer/Lilly; Lung Cancer Research Foundation; Lungevity; NIH; OncLive/MJH Life Sciences; PER; Pfizer; Remedica; Remedica; Research to Practice; RV More; Sirio Libanes Hospital; TP Therapeutics; Verastem
Consulting or Advisory Role - 14ner Oncology/Elevation Oncology; Abbvie; Amgen; Applied Pharmaceutical Science; Archer; AstraZeneca; Axis Pharma; Bayer; BeiGene; BerGenBio; Blueprint Medicines; Clinical Care Options; Clinical Care Options; EMD Serono/Merck; Entos; EPG Health; Exelixis; Genentech/Roche; Hengrui Therapeutics; Ignyta; Janssen; Journal of the National Comprehensive Cancer Network; Liberum; Lilly; Loxo; Med Learning; Medscape; Melendi; Merus; Monopteros Therapeutics; MORE Health; Novartis; Nuvalent, Inc.; Ology Medical Education; Ology Medical Education; PeerView; Pfizer; Prelude Therapeutics; Repare Therapeutics; Takeda/Millennium; touchIME; Treeline Biosciences; Tyra Biosciences
Research Funding - Foundation Medicine
Patents, Royalties, Other Intellectual Property - Wolters Kluwer (Royalties for Pocket Oncology)
Other Relationship - Boehringer Ingelheim; GlaxoSmithKline; Merck; Merus; Pfizer; Pfizer; PharmaMar; Puma Biotechnology; Taiho Pharmaceutical; Teva
 
Michal Zapotocky
Consulting or Advisory Role - AstraZeneca/Merck
 
Christina Coleman Abadi
No Relationships to Disclose
 
Marc Barritault
Employment - OtR3 (I)
Leadership - OtR3 (I)
Stock and Other Ownership Interests - OtR3 (I)
Research Funding - Roche (Inst)
Patents, Royalties, Other Intellectual Property - OtR3 (I)
Travel, Accommodations, Expenses - AstraZeneca/Merck; Pfizer; Roche
 
Pierre Leblond
No Relationships to Disclose
 
Uri Tabori
No Relationships to Disclose
 
Jordan R. Hansford
No Relationships to Disclose
 
Craig Erker
No Relationships to Disclose
 
Francois Doz
Consulting or Advisory Role - Bayer (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Loxo (Inst); Roche (Inst); SERVIER (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Roche
 
Theodore Willis Laetsch
Consulting or Advisory Role - Advanced Microbubbles; AI Therapeutics; Aptitude Health; Bayer; Cellectis; Clinical Education Alliance; Deciphera; Jazz Pharmaceuticals; Jumo Health; Massive Bio; Med Learning Group; Medscape; Novartis; Physicans' Education Resource; Y-mAbs Therapeutics
Research Funding - Abbvie (Inst); Amgen (Inst); Atara Biotherapeutics (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Epizyme (Inst); Foundation Medicine (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Jubilant Pharmaceuticals (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Novella Clinical (Inst); Pfizer (Inst); SERVIER (Inst); Turning Point Therapeutics (Inst)
 
Sébastien Perreault
Stock and Other Ownership Interests - Novocure
Consulting or Advisory Role - AstraZeneca Canada; Bayer; Eisai
Research Funding - Novartis